image credit: Pixabay

Fight for Sight funded researcher develops gene therapy approach for glaucoma

March 11, 2020

A Fight for Sight funded researcher from the University of Bristol has used gene editing techniques to successfully demonstrate a gene therapy for glaucoma in the lab, in results published in Molecular Therapy in March.

Glaucoma is the second leading cause of blindness for which there is currently no cure.

In a lab setting, the researcher used a gene-editing technique called CRISPR to alter genetic information when transferred into eye cells using a harmless virus.

Read More on Medical News